Laboratorios Litaphar Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Laboratorios Litaphar General Information
Description
Developer and distributor of therapeutic solutions for illnesses related to women. The company's genetic and therapeutic pharmaceutical products offer cures for diseases related to gynecology and obstetrics of prostaglandin analogs, progesterone receptor antagonists and selective modulators of progesterone receptors, enabling women patients to recover from illness and improve their sexuality and vulvar health.
Contact Information
Website
www.litaphar.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Parent Company
Primary Office
- Loiolabide, 7
- 20730 Azpeitia
- Spain
+34 943 00 00 00
Laboratorios Litaphar Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Laboratorios Litaphar Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ander Larrañaga | General Manager, Business Development Manager |